Boardroom Alpha
Start trial
8-K primary document
MX · Current Report (Form 8-K) · Filed January 14, 2026

Magnachip Semiconductor Corp — 8-K exhibit

d25690dex991.htm
Magnachip Semiconductor Corp on Boardroom Alpha
EX-99.1

Exhibit 99.1

 

LOGO

Magnachip Announces the Retirement of Director Ilbok Lee

SEOUL, South Korea, Jan. 14, 2026 – Magnachip Semiconductor Corporation (NYSE: MX) (“Magnachip” or the “Company”) today announced that Ilbok Lee has notified the Company of his intention to retire from the Company’s Board of Directors, to be effective at the Company’s next scheduled Board meeting to be held on January 14, 2026.

Dr. Lee joined Magnachip’s Board in August 2011 and has served in multiple capacities for the Board during that time, including as Chair of the Nominating and Corporate Governance Committee, and as a member of the Board’s Audit, Risk and Strategic Review Committees. During his tenure, Dr. Lee provided critical insight across a broad range of strategic, operational, and governance matters, and has been widely respected for his deep technical insight, thoughtful judgment, and unwavering commitment to the Company, its employees, and its values.

“Over more than fourteen years of service, Dr. Lee has made a lasting and meaningful contribution to our Company and our Board,” said Camillo Martino, Magnachip’s Chairman of the Board. “He consistently brought clarity, perspective, and experience to our discussions, while always approaching the role with humility and integrity. His guidance has been invaluable to both management and the Board, and his impact on the Company will be felt for many years to come. We extend our sincere thanks and deep respect for his many years of service and lasting contribution.”

Dr. Lee’s departure is due to personal reasons and is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

About Magnachip Semiconductor

Magnachip is a designer and manufacturer of analog and mixed-signal power semiconductor platform solutions for various applications, including industrial, automotive, communication, consumer and computing. The Company provides a broad range of standard products to customers worldwide. Magnachip, with about 45 years of operating history, owns a portfolio of approximately 1,000 registered patents and pending applications, and has extensive engineering, design and manufacturing process expertise. For more information, please visit www.magnachip.com. Information on or accessible through Magnachip’s website is not a part of, and is not incorporated into, this release.

CONTACT:

Mike Bishop

Bishop IR, LLC

Tel. +1 (415) 891-9633

mike@bishopir.com

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer